Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Paula Martinez Sanz; Dieke J. van Rees; Hanke L. Matlung; Godelieve A. M. Tytgat; Katka Franke

doi:10.1136/jitc-2021-003983

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Paula Martinez Sanz^*
, Dieke J. van Rees
, Hanke L. Matlung
, Godelieve A. M. Tytgat
, Katka Franke

^*Corresponding author for this work

Sanquin Blood Supply Foundation
Princess Maxima Center of Pediatric Oncology, 3584, Netherlands
Princess Máxima Center for Pediatric Oncology

Research output: Contribution to journal › Comment/Letter to the editor › Academic

35 Downloads (Pure)

Original language	English
Article number	e003983
Journal	Journal for immunotherapy of cancer
Volume	9
Issue number	12
DOIs	https://doi.org/10.1136/jitc-2021-003983
Publication status	Published - 1 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cytokines
immunotherapy
neuroblastoma

Access to Document

10.1136/jitc-2021-003983

Response-to.pdfFinal published version, 197 KBLicence: CC BY

Cite this

@article{29adf104e3ae449d9aed3d0fe0583ed3,

title = "Response to: Correspondence on {"}g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment{"} by Mora et al",

keywords = "cytokines, immunotherapy, neuroblastoma",

author = "\{Martinez Sanz\}, Paula and \{van Rees\}, \{Dieke J.\} and Matlung, \{Hanke L.\} and Tytgat, \{Godelieve A. M.\} and Katka Franke",

year = "2021",

month = dec,

day = "1",

doi = "10.1136/jitc-2021-003983",

language = "English",

volume = "9",

journal = "Journal for immunotherapy of cancer",

issn = "2051-1426",

publisher = "BioMed Central Ltd.",

number = "12",

}

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al. / Martinez Sanz, Paula; van Rees, Dieke J.; Matlung, Hanke L. et al.
In: Journal for immunotherapy of cancer, Vol. 9, No. 12, e003983, 01.12.2021.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Response to

T2 - Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

AU - Martinez Sanz, Paula

AU - van Rees, Dieke J.

AU - Matlung, Hanke L.

AU - Tytgat, Godelieve A. M.

AU - Franke, Katka

PY - 2021/12/1

Y1 - 2021/12/1

KW - cytokines

KW - immunotherapy

KW - neuroblastoma

UR - https://www.scopus.com/pages/publications/85122483698

UR - https://www.ncbi.nlm.nih.gov/pubmed/34893526

UR - https://www.scopus.com/pages/publications/85122483698

U2 - 10.1136/jitc-2021-003983

DO - 10.1136/jitc-2021-003983

M3 - Comment/Letter to the editor

C2 - 34893526

SN - 2051-1426

VL - 9

JO - Journal for immunotherapy of cancer

JF - Journal for immunotherapy of cancer

IS - 12

M1 - e003983

ER -

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

UN SDGs

Keywords

Access to Document

Other files and links

Cite this